Annual CFI
N/A
December 1, 2024
Summary
- ABBV annual cash flow from investing activities is not available.
Performance
ABBV Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFI
N/A
December 1, 2024
Summary
- ABBV quarterly cash flow from investing activities is not available.
Performance
ABBV Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFI
N/A
December 1, 2024
Summary
- ABBV TTM cash flow from investing activities is not available.
Performance
ABBV TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ABBV Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ABBV Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
AbbVie Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$8.26 B(+649.2%) | -$19.75 B(+66.5%) |
| Jun 2024 | - | -$1.10 B(-88.5%) | -$11.86 B(+6.9%) |
| Mar 2024 | - | -$9.59 B(+1098.5%) | -$11.10 B(+452.4%) |
| Dec 2023 | -$2.01 B(+222.5%) | -$800.00 M(+116.8%) | -$2.01 B(+21.2%) |
| Sep 2023 | - | -$369.00 M(+8.2%) | -$1.66 B(>+9900.0%) |
| Jun 2023 | - | -$341.00 M(-31.7%) | -$2.00 M(-100.4%) |
| Mar 2023 | - | -$499.00 M(+11.4%) | $469.00 M(-175.3%) |
| Dec 2022 | -$623.00 M(-73.4%) | -$448.00 M(-134.8%) | -$623.00 M(-52.8%) |
| Sep 2022 | - | $1.29 B(+889.2%) | -$1.32 B(-59.0%) |
| Jun 2022 | - | $130.00 M(-108.2%) | -$3.22 B(-10.4%) |
| Mar 2022 | - | -$1.59 B(+39.0%) | -$3.59 B(+53.3%) |
| Dec 2021 | -$2.34 B(-93.8%) | -$1.15 B(+86.2%) | -$2.34 B(+28.4%) |
| Sep 2021 | - | -$615.00 M(+154.1%) | -$1.83 B(-22.6%) |
| Jun 2021 | - | -$242.00 M(-29.2%) | -$2.36 B(-93.8%) |
| Mar 2021 | - | -$342.00 M(-45.5%) | -$37.77 B(+0.6%) |
| Dec 2020 | -$37.56 B(-6401.5%) | -$627.00 M(-45.4%) | -$37.56 B(+0.0%) |
| Sep 2020 | - | -$1.15 B(-96.8%) | -$37.55 B(+7.2%) |
| Jun 2020 | - | -$35.65 B(>+9900.0%) | -$35.02 B(-7188.7%) |
| Mar 2020 | - | -$129.00 M(-79.0%) | $494.00 M(-17.1%) |
| Dec 2019 | $596.00 M(-159.2%) | -$615.00 M(-144.6%) | $596.00 M(-35.8%) |
| Sep 2019 | - | $1.38 B(-1084.3%) | $928.00 M(-165.7%) |
| Jun 2019 | - | -$140.00 M(+418.5%) | -$1.41 B(+141.1%) |
| Mar 2019 | - | -$27.00 M(-90.5%) | -$586.00 M(-41.7%) |
| Dec 2018 | -$1.01 B(+267.2%) | -$283.00 M(-70.6%) | -$1.01 B(+92.7%) |
| Sep 2018 | - | -$963.00 M(-240.2%) | -$522.00 M(-257.2%) |
| Jun 2018 | - | $687.00 M(-253.7%) | $332.00 M(-997.3%) |
| Mar 2018 | - | -$447.00 M(-322.4%) | -$37.00 M(-86.5%) |
| Dec 2017 | -$274.00 M | $201.00 M(-284.4%) | -$274.00 M(-53.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | -$109.00 M(-134.3%) | -$594.00 M(-13.2%) |
| Jun 2017 | - | $318.00 M(-146.5%) | -$684.00 M(-87.1%) |
| Mar 2017 | - | -$684.00 M(+474.8%) | -$5.30 B(-12.7%) |
| Dec 2016 | -$6.07 B(-53.0%) | -$119.00 M(-40.2%) | -$6.07 B(-2.8%) |
| Sep 2016 | - | -$199.00 M(-95.4%) | -$6.25 B(+17.8%) |
| Jun 2016 | - | -$4.30 B(+194.8%) | -$5.31 B(-60.7%) |
| Mar 2016 | - | -$1.46 B(+390.9%) | -$13.52 B(+4.5%) |
| Dec 2015 | -$12.94 B(+1297.0%) | -$297.00 M(-139.9%) | -$12.94 B(+27.8%) |
| Sep 2015 | - | $745.00 M(-106.0%) | -$10.13 B(-23.0%) |
| Jun 2015 | - | -$12.51 B(+1333.1%) | -$13.15 B(+1212.8%) |
| Mar 2015 | - | -$873.00 M(-134.7%) | -$1.00 B(+8.2%) |
| Dec 2014 | -$926.00 M(-205.3%) | $2.51 B(-210.1%) | -$926.00 M(-72.1%) |
| Sep 2014 | - | -$2.28 B(+536.2%) | -$3.32 B(+66.1%) |
| Jun 2014 | - | -$359.00 M(-55.0%) | -$2.00 B(+42.1%) |
| Mar 2014 | - | -$797.00 M(-748.0%) | -$1.41 B(-259.8%) |
| Dec 2013 | $879.00 M(-136.4%) | $123.00 M(-112.8%) | $879.00 M(+59.8%) |
| Sep 2013 | - | -$964.00 M(-513.7%) | $550.00 M(-288.4%) |
| Jun 2013 | - | $233.00 M(-84.3%) | -$292.00 M(-59.8%) |
| Mar 2013 | - | $1.49 B(-821.8%) | -$727.00 M(-69.9%) |
| Dec 2012 | -$2.42 B(-537.3%) | -$206.00 M(-88.6%) | -$2.42 B(+42.0%) |
| Sep 2012 | - | -$1.81 B(+794.1%) | -$1.70 B(-395.1%) |
| Jun 2012 | - | -$202.00 M(-1.0%) | $577.02 M(+33.1%) |
| Mar 2012 | - | -$204.00 M(-140.1%) | $433.64 M(-21.6%) |
| Dec 2011 | $553.00 M(-111.0%) | $508.92 M(+7.3%) | $553.00 M(+1154.7%) |
| Sep 2011 | - | $474.10 M(-237.3%) | $44.08 M(-110.2%) |
| Jun 2011 | - | -$345.38 M(+308.1%) | -$430.02 M(+408.1%) |
| Mar 2011 | - | -$84.64 M | -$84.64 M |
| Dec 2010 | -$5.03 B(+934.4%) | - | - |
| Dec 2009 | -$486.36 M | - | - |
FAQ
- What is the all time high annual CFI for AbbVie?
- What is the all time high quarterly CFI for AbbVie?
- What is the all time high TTM CFI for AbbVie?
What is the all time high annual CFI for AbbVie?
AbbVie all-time high annual cash flow from investing activities is $879.00 M
What is the all time high quarterly CFI for AbbVie?
AbbVie all-time high quarterly cash flow from investing activities is $2.51 B
What is the all time high TTM CFI for AbbVie?
AbbVie all-time high TTM cash flow from investing activities is $928.00 M